These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27737875)

  • 1. Using Large-Scale Linkage Data to Evaluate the Effectiveness of a National Educational Program on Antithrombotic Prescribing and Associated Stroke Prevention in Primary Care.
    Liu Z; Moorin R; Worthington J; Tofler G; Bartlett M; Khan R; Zuo Y
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27737875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving cardiovascular disease management in Australia: NPS MedicineWise.
    Gadzhanova SV; Roughead EE; Bartlett MJ
    Med J Aust; 2013 Aug; 199(3):192-5. PubMed ID: 23909542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of NPS MedicineWise general practitioner education programs and Choosing Wisely Australia recommendations on prescribing of proton pump inhibitors in Australia.
    Wu J; Dickinson S; Elgebaly Z; Blogg S; Heaney A; Soo Y; Daniels B; Weekes L
    BMC Fam Pract; 2020 May; 21(1):85. PubMed ID: 32386520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancy between guidelines for stroke prevention in atrial fibrillation and practice patterns in primary care. The nationwide French AFIGP survey.
    Sabouret P; Bricard M; Hermann MA; Cotté FE; Deret-Bixio L; Rushton-Smith S
    Arch Cardiovasc Dis; 2015 Nov; 108(11):544-53. PubMed ID: 26113478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of changing guidelines on prescribing aspirin for primary prevention of cardiovascular events.
    Hissett J; Folks B; Coombs L; Leblanc W; Pace WD
    J Am Board Fam Med; 2014; 27(1):78-86. PubMed ID: 24390889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why are eligible patients not prescribed aspirin in primary care? A qualitative study indicating measures for improvement.
    Short D; Frischer M; Bashford J; Ashcroft D
    BMC Fam Pract; 2003 Jul; 4():9. PubMed ID: 12871601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation.
    Jackson SL; Peterson GM; Vial JH
    Ann Pharmacother; 2004 Nov; 38(11):1794-9. PubMed ID: 15454583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
    Carlsson AC; Wändell P; Gasevic D; Sundquist J; Sundquist K
    Int J Cardiol; 2015; 187():547-52. PubMed ID: 25863300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid change in prescribing behavior in hospitals participating in get with the guidelines-stroke after release of the management of atherothrombosis with clopidogrel in high-risk patients (MATCH) clinical trial results.
    Menon BK; Frankel MR; Liang L; Labresh KA; Ellrodt G; Hernandez AF; Fonarow GC; Schwamm LH; Smith EE;
    Stroke; 2010 Sep; 41(9):2094-7. PubMed ID: 20634476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A short-term risk-benefit analysis of occasional and regular use of low-dose aspirin in primary prevention of vascular diseases: a nationwide population-based study.
    Wu IC; Hsieh HM; Wu MT
    BMJ Open; 2015 Jan; 5(1):e006694. PubMed ID: 25575876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study.
    Bousser MG; Amarenco P; Chamorro A; Fisher M; Ford I; Fox K; Hennerici MG; Mattle HP; Rothwell PM;
    Cerebrovasc Dis; 2009; 27(5):509-18. PubMed ID: 19372653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of data from the six primary prevention trials of cardiovascular events using aspirin.
    Bartolucci AA; Howard G
    Am J Cardiol; 2006 Sep; 98(6):746-50. PubMed ID: 16950176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of aspirin and statins for the primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus infection.
    Park TE; Yusuff J; Sharma R
    Int J STD AIDS; 2016 May; 27(6):447-52. PubMed ID: 25957325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of aspirin for primary and secondary cardiovascular disease prevention in the United States, 2011-2012.
    Mainous AG; Tanner RJ; Shorr RI; Limacher MC
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25023071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk.
    Tomlin AM; Lloyd HS; Tilyard MW
    Eur J Prev Cardiol; 2017 Feb; 24(3):311-319. PubMed ID: 27798365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The specificity of prescription patterns in secondary stroke prevention.
    Bellelli G; Trabucchi M
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):512; author reply 512. PubMed ID: 14966188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.